FBLG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Fibrobiologics Inc (FBLG) is not a strong buy for a beginner investor with a long-term focus at this time. While there is insider buying activity and a positive MACD, the financial performance remains weak, with declining EPS and negative net income. Additionally, the lack of significant trading trends, absence of recent news, and no strong signals from Intellectia Proprietary Trading Signals suggest that this stock does not currently present a compelling investment opportunity.
The MACD histogram is positive but contracting, indicating a weakening bullish momentum. RSI is neutral at 41.873, and moving averages are converging, showing no clear trend. The stock is trading below the pivot level of 0.388, with key support at 0.319 and resistance at 0.457.
Insiders are buying, with a 358.82% increase in buying activity over the last month. The MACD remains positive, suggesting some bullish sentiment.
There is no recent news or significant trading trends to support a bullish case.
In Q4 2025, revenue remained at 0 with no growth YoY. Net income improved slightly by 4.68% YoY but remains negative at -$3,244,000. EPS dropped significantly by 44.44% YoY to -0.05, indicating worsening profitability.
H.C. Wainwright has maintained a Buy rating but lowered the price target from $5 to $4, reflecting a more cautious outlook on the stock.
